ARTELO BIOSCIENCES, INC. (ARTL) — key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Net Income/Loss (FY2025)

-$12.9M

Total Assets (FY2025)

$2.8M

Total Equity (FY2025)

-$1.3M

Cash Flows from Operating Activities (FY2025)

-$8.5M

Source: ARTELO BIOSCIENCES, INC. 10-K filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.